v3.26.1
Condensed Consolidated Statements of Income - USD ($)
shares in Millions
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Total revenues $ 2,986,900,000 $ 2,770,200,000
Costs and expenses:    
Cost of sales 392,800,000 363,000,000.0
Research and development expenses 961,600,000 979,700,000
Acquired in-process research and development expenses 500,000 19,800,000
Selling, general and administrative expenses 493,700,000 396,400,000
Intangible asset impairment charge 0 379,000,000.0
Change in fair value of contingent consideration 200,000 2,200,000
Total costs and expenses 1,848,800,000 2,140,100,000
Income from operations 1,138,100,000 630,100,000
Interest income, net 114,800,000 117,900,000
Other expense, net 0 (17,600,000)
Income before Provision for income taxes 1,252,900,000 730,400,000
Provision for income taxes 221,500,000 84,100,000
Net income $ 1,031,400,000 $ 646,300,000
Net income per common share:    
Basic (in dollars per share) $ 4.06 $ 2.52
Diluted (in dollars per share) $ 4.02 $ 2.49
Shares used in per share calculations:    
Basic (in shares) 254.1 256.9
Diluted (in shares) 256.3 259.5
Product revenues, net    
Total revenues $ 2,986,900,000 $ 2,760,200,000
Other revenues    
Total revenues $ 0 $ 10,000,000.0